Expert Interview
Discussing the data from Cohort 1 from the 4D-710 phase 1/2 AEROW trial from 4D Molecular Therapeutics in treating cystic fibrosis
Ticker(s): FDMT, VRTXInstitution: Columbia University Medical Center
- Professor of Medicine at CUMC & Director of the Columbia University Gunnar Esiason Adult Cystic Fibrosis (CF) Program and the Asthma Research Program.
- Manages 100 patients with non-CF bronchiectasis and 175 patients with cystic fibrosis.
- Serves as Principal Investigator for numerous research projects in the areas of cystic fibrosis and asthma.
What are your thoughts on 4D-710 so far?
Added By: wilson_adminWould you ever consider using a gene therapy in CF over correctors?
Added By: wilson_adminHow much demand is there among adult patients for a potential one and done treatment?
Added By: wilson_adminAre You Interested In These Questions?
Slingshot Insights Explained
Expert research benefits investors by giving them timely access to unbiased real world perspectives on highly specialized topics. Slingshot Insights' crowdfunded model makes this access available at a fraction of the cost of other expert networks.
Reason
*Slingshot Insights provides access to information, not investment advice. We work to support you and facilitate access to experts; however we are not responsible for monitoring calls for the disclosure of MNPI. You should obtain financial, legal and tax advice from your qualified and licensed advisers before deciding to invest in any security.
